Extracellular protein secretion of cultured normal and Pagetic osteoblasts.
Two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) has been used to map the extracellular secretory activity of normal osteoblasts. The proteins osteonectin, bone sialoprotein, and both the C-telopeptide of collagen I together with collagen I have now been positionally identified. In addition the secretory differences which exist between normal and Pagetic osteoblasts have been mapped with the Pagetic osteoblasts shown to consistently secrete an altered 30 kDa C-telopeptide of collagen type I. The use of the diphosphonate Pamidronate in the treatment of Paget's disease of bone has beneficial effects with suppression of the bone isoenzyme marker alkaline phosphatase. It has been reported that diphosphonates directly inhibit human osteoblast secretory function as well as osteoclast metabolism. The effects of Pamidronate on the secretory activity of normal and Pagetic osteoblast cultures was also investigated. The extracellular protein secretion of normal and Pagetic osteoblasts was not affected by Pamidronate treatment as assessed by 2-D PAGE. This technique allows a comprehensive multiparameter assessment of extracellular secretory activity in normal and diseased states. The findings show that the Pagetic osteoblasts cultured in vitro are functionally abnormal and they support the hypothesis that the underlying problem in Paget's disease is characterised by disorder of osteoblast and osteoclast interactions.
Hankey
D P
DP
School of Biomedical Sciences/Anatomy, Queen's University of Belfast, Northern Ireland.
Hughes
A E
AE
Mollan
R A
RA
Nicholas
R M
RM
D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D015153:Blotting, Western; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D015232:Dinoprostone / Q000494:pharmacology; D004164:Diphosphonates / Q000494:pharmacology; D015180:Electrophoresis, Gel, Two-Dimensional; D016326:Extracellular Matrix Proteins / Q000378:metabolism*; D006801:Humans; D007526:Isoelectric Point; D008875:Middle Aged; D008970:Molecular Weight; D010001:Osteitis Deformans / Q000503:physiopathology*; D010006:Osteoblasts / Q000187:drug effects / Q000502:physiology*; D000077268:Pamidronate
D004164:Diphosphonates; D016326:Extracellular Matrix Proteins; D003094:Collagen; D000242:Cyclic AMP; D000469:Alkaline Phosphatase; D015232:Dinoprostone; D000077268:Pamidronate